Related Experiment Videos

[Superoxide production of polymorphonuclear leukocytes in endotoxin shock and antioxidative effect of coenzyme Q10]

H Suzuki1

  • 1First Department of Surgery, Nippon Medical School, Tokyo, Japan.

Nihon Ika Daigaku Zasshi
|April 1, 1991
PubMed

Insights

Endotoxin shock significantly increases polymorphonuclear leukocyte (PMN) superoxide production and liver lipid peroxide. Coenzyme Q10 effectively mitigates these effects, offering an anti-endotoxin shock therapy.

Area of Science:

  • Biochemistry
  • Immunology
  • Pharmacology

Context:

  • Endotoxemia is a critical condition characterized by systemic inflammation.
  • Polymorphonuclear leukocytes (PMN) play a key role in the inflammatory response.
  • Oxidative stress, indicated by superoxide production and lipid peroxidation, is a hallmark of endotoxin shock.

Purpose:

  • To investigate the impact of endotoxin administration on PMN superoxide production.
  • To evaluate the role of lipid peroxide accumulation in the liver during endotoxin shock.
  • To determine the potential therapeutic effect of coenzyme Q10 on these pathological processes.

Summary:

  • Intravenous endotoxin administration in rats led to a 13-fold increase in PMN superoxide production and elevated liver lipid peroxide levels.
  • Coenzyme Q10 treatment significantly reduced PMN superoxide production and inhibited hepatic lipid peroxidation in endotoxin-shocked rats.
  • These results indicate that endotoxin primes PMN for enhanced superoxide release and induces oxidative damage.

Impact:

  • Coenzyme Q10 demonstrates a protective effect against endotoxin shock by modulating key oxidative stress markers.
  • Findings suggest coenzyme Q10 as a potential therapeutic agent for managing endotoxemia and its associated complications.
  • This study elucidates the mechanisms underlying endotoxin-induced oxidative stress and the antioxidant capacity of coenzyme Q10.

Related Concept Videos